Show simple item record

dc.contributor.authorMetastasio, Antonio
dc.contributor.authorPrevete, Elisabeth
dc.contributor.authorSingh, Darshan
dc.contributor.authorGrundmann, Oliver
dc.contributor.authorProzialeck, Walter C.
dc.contributor.authorVeltri, Charles
dc.contributor.authorBersani, Giuseppe
dc.contributor.authorCorazza, Ornella
dc.date.accessioned2021-01-07T00:09:09Z
dc.date.available2021-01-07T00:09:09Z
dc.date.issued2020-11-19
dc.identifier.citationMetastasio , A , Prevete , E , Singh , D , Grundmann , O , Prozialeck , W C , Veltri , C , Bersani , G & Corazza , O 2020 , ' Can Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Study ' , Frontiers in Psychiatry , vol. 11 , 594816 . https://doi.org/10.3389/fpsyt.2020.594816
dc.identifier.issn1664-0640
dc.identifier.otherORCID: /0000-0001-7371-319X/work/98163993
dc.identifier.urihttp://hdl.handle.net/2299/23643
dc.description© 2020 Metastasio, Prevete, Singh, Grundmann, Prozialeck, Veltri, Bersani and Corazza. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY - https://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
dc.description.abstractAmong the symptoms of COVID-19 fever, general malaise, pain and aches, myalgia, fatigue, and headache can affect the quality of life of patients, even after the end of the acute phase of the infection and can be long lasting. The current treatment of these symptoms, also because COVID-19 patients have been asked not to use non-steroidal anti-inflammatory drugs (NSAIDs), in particular ibuprofen are often unsatisfactory. Among the above mentioned symptoms malaise and fatigue seem the most difficult to treat. In this case report we describe the use of kratom (Mitragyna speciosa) by a patient with confirmed COVID-19 infection. What we observed was a fast and sustained relieve of the above mentioned symptoms.en
dc.format.extent6
dc.format.extent204588
dc.language.isoeng
dc.relation.ispartofFrontiers in Psychiatry
dc.subjectCOVID-19
dc.subjectkratom
dc.subjectlong covid
dc.subjectnew psychoactive substances
dc.subjectnew treatments
dc.subjectopioid
dc.subjectstimulants
dc.subjectPsychiatry and Mental health
dc.titleCan Kratom (Mitragyna speciosa) Alleviate COVID-19 Pain? A Case Studyen
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Pharmacy, Pharmacology and Postgraduate Medicine
dc.description.statusPeer reviewed
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85097223872&partnerID=8YFLogxK
rioxxterms.versionofrecord10.3389/fpsyt.2020.594816
rioxxterms.typeJournal Article/Review
herts.preservation.rarelyaccessedtrue


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record